Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mehri Ghorashi, Mohammad Ali Rezaee, Mohammad Jafar Rezaie, Mehdi Mohammadi, Ali Jalili & Mohammad Reza Rahmani. (2017) The attenuating effect of aqueous extract of licorice on bleomycin-induced pulmonary fibrosis in mice. Food and Agricultural Immunology 28:1, pages 67-77.
Read now
Read now
Deborah E. Sullivan, MaryBeth Ferris, Derek Pociask & Arnold R. Brody. (2008) The Latent Form of TGFβ1 is Induced by TNFα Through an ERK Specific Pathway and is Activated by Asbestos-Derived Reactive Oxygen Species In Vitro and In Vivo. Journal of Immunotoxicology 5:2, pages 145-149.
Read now
Read now
Articles from other publishers (22)
Yetkin Agackiran, Husamettin Gul, Ersin Gunay, Nalan Akyurek, Leyla Memis, Sibel Gunay, Yusuf Sinan Sirin & Tayfun Ide. (2012) The Efficiency of Proanthocyanidin in an Experimental Pulmonary Fibrosis Model: Comparison with Taurine. Inflammation 35:4, pages 1402-1410.
Crossref
Crossref
Helen Valentine, Erin K. Daugherity, Bhupinder Singh & Kirk J. Maurer. 2012. The Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents. The Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents
875
906
.
Xin Wang, Lina Lv, Ying Chen & Jie Chen. (2010) A CD36 synthetic peptide inhibits silica-induced lung fibrosis in the mice. Toxicology and Industrial Health 26:1, pages 47-53.
Crossref
Crossref
Xin Wang, Ying Chen, Lina Lv & Jie Chen. (2009) Silencing CD36 gene expression results in the inhibition of latent-TGF-β1 activation and suppression of silica-induced lung fibrosis in the rat. Respiratory Research 10:1.
Crossref
Crossref
Ying Chen, Xin Wang, Dong Weng, Lujia Tian, Lina Lv, Shasha Tao & Jie Chen. (2009) A TSP-1 synthetic peptide inhibits bleomycin-induced lung fibrosis in mice. Experimental and Toxicologic Pathology 61:1, pages 59-65.
Crossref
Crossref
Keizo Sato, Yasumasa Tashiro, Satsuki Chibana, Akihisa Yamashita, Tomohiro Karakawa & Hirotsugu Kohrogi. (2008) Role of Lipid-Derived Free Radical in Bleomycin-Induced Lung Injury in Mice: Availability for ESR Spin Trap Method with Organic Phase Extraction. Biological and Pharmaceutical Bulletin 31:10, pages 1855-1859.
Crossref
Crossref
Antje Moeller, Kjetil Ask, David Warburton, Jack Gauldie & Martin Kolb. (2008) The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?. The International Journal of Biochemistry & Cell Biology 40:3, pages 362-382.
Crossref
Crossref
Sonia B. JakowlewPatricia J. Sime, R. Matthew Kottmann, Heather F. Lakatos & Thomas H. Thatcher. 2008. Transforming Growth Factor-β in Cancer Therapy, Volume I. Transforming Growth Factor-β in Cancer Therapy, Volume I
629
647
.
Sonia B. JakowlewNasreen Khalil & Robert O’Connor. 2008. Transforming Growth Factor-β in Cancer Therapy, Volume I. Transforming Growth Factor-β in Cancer Therapy, Volume I
581
594
.
Huimin Zhang, William E. Lawson, Vasiliy V. Polosukhin, Ambra Pozzi, Timothy S. Blackwell, Ying Litingtung & Chin Chiang. (2007) Inhibitor of Differentiation 1 Promotes Endothelial Survival in a Bleomycin Model of Lung Injury in Mice. The American Journal of Pathology 171:4, pages 1113-1126.
Crossref
Crossref
Arnold Brody & Deborah Sullivan. 2006. Particle Toxicology. Particle Toxicology
227
244
.
Søren M. Bentzen. (2006) Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nature Reviews Cancer 6:9, pages 702-713.
Crossref
Crossref
Luciano Paulino Silva, Ana Paula Catunda Lemos, Rui Curi & Ricardo Bentes Azevedo. (2006) Effects of fish oil treatment on bleomycin-induced pulmonary fibrosis in mice. Cell Biochemistry and Function 24:5, pages 387-396.
Crossref
Crossref
M. Selman, C. Navarro & M. Gaxiola. (2005) Fibrosis pulmonar idiopática: en busca de un tratamiento eficaz. Archivos de Bronconeumología 41, pages 15-20.
Crossref
Crossref
Craig R. Kunz, Martin R. Jadus, Gary D. Kukes, Françoise Kramer, Vu N. Nguyen & Scott A. Sasse. (2004) Intrapleural Injection of Transforming Growth Factor-β Antibody Inhibits Pleural Fibrosis in Empyema. Chest 126:5, pages 1636-1644.
Crossref
Crossref
Y-C Shen, C-F Chiu, K-C Chow, C-L Chen, Y-C Liaw & S-P Yeh. (2004) Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-β1 and cyclooxygenase-2. Bone Marrow Transplantation 34:7, pages 609-614.
Crossref
Crossref
Markella Ponticos, David Abraham, Catherine Alexakis, Qi-Long Lu, Carol Black, Terence Partridge & George Bou-Gharios. (2004) Col1a2 enhancer regulates collagen activity during development and in adult tissue repair. Matrix Biology 22:8, pages 619-628.
Crossref
Crossref
Sergei P Atamas & Barbara White. (2003) Cytokine regulation of pulmonary fibrosis in scleroderma. Cytokine & Growth Factor Reviews 14:6, pages 537-550.
Crossref
Crossref
Sergei P. Atamas & Barbara White. (2003) The role of chemokines in the pathogenesis of scleroderma. Current Opinion in Rheumatology 15:6, pages 772-777.
Crossref
Crossref
Yosef S. Haviv, Koichi Takayama, Peter A. Nagi, Albert Tousson, William Cook, Minghui Wang, John T. Lam, Seiji Naito, Xiaosheng Lei, Delicia E. Carey & David T. Curiel. (2003) Modulation of renal glomerular disease using remote delivery of adenoviral-encoded solubletype II TGF-β receptor fusion molecule. The Journal of Gene Medicine 5:10, pages 839-851.
Crossref
Crossref
P. M. Lackie & R. C. Benyon. (2003) What can be learned about the fibrosis of asthma from rodent models?. Clinical & Experimental Allergy 33:5, pages 546-549.
Crossref
Crossref
Shri N. Giri. (2003) Novel Pharmacological Approaches to Manage Interstitial Lung Fibrosis in the Twenty-First Century. Annual Review of Pharmacology and Toxicology 43:1, pages 73-95.
Crossref
Crossref